News Updates
More Articles
- The Pitfalls and Promise of Cell and Gene Therapy Development: A Time for Concerted Action
- “Not Just Checking a Box”: A Call to Rethink Patient Involvement in the EU
- From Cells to Animals and Back Again: The Shifting Landscape of Cancer Efficacy and Safety Models
- Addressing Inequity: Embedding Inclusion and Diversity in UK Clinical Trials
- The Next AI Revolution: Computer System Validation
DIA Global Annual Meeting 2021: A Year Like No Other: COVID-19 and the US FDA’s Response
In June 2021, CBER Director Peter Marks and CDER Director Patrizia Cavazzoni joined Acting FDA Commissioner Janet Woodcock for the DIA 2021 Global Annual Meeting FDA Town Hall discussion to look back at whether and how the FDA, as a public health agency at its core, has risen to the many COVID-related challenges it faced.